- Home
- SER vs NXN Comparison
SER vs NXN Comparison
Compare SER & NXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- NXN
- Stock Information
- Founded
- SER 2017
- NXN 1992
- Country
- SER United States
- NXN United States
- Employees
- SER N/A
- NXN N/A
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- NXN Trusts Except Educational Religious and Charitable
- Sector
- SER Health Care
- NXN Finance
- Exchange
- SER Nasdaq
- NXN Nasdaq
- Market Cap
- SER 47.5M
- NXN 45.5M
- IPO Year
- SER 2018
- NXN N/A
- Fundamental
- Price
- SER $4.73
- NXN $11.79
- Analyst Decision
- SER
- NXN
- Analyst Count
- SER 0
- NXN 0
- Target Price
- SER N/A
- NXN N/A
- AVG Volume (30 Days)
- SER 10.3K
- NXN 9.7K
- Earning Date
- SER 11-12-2024
- NXN 01-01-0001
- Dividend Yield
- SER N/A
- NXN 4.23%
- EPS Growth
- SER N/A
- NXN N/A
- EPS
- SER N/A
- NXN 0.24
- Revenue
- SER $3,157,500.00
- NXN N/A
- Revenue This Year
- SER N/A
- NXN N/A
- Revenue Next Year
- SER N/A
- NXN N/A
- P/E Ratio
- SER N/A
- NXN $48.42
- Revenue Growth
- SER 2454.55
- NXN N/A
- 52 Week Low
- SER $3.81
- NXN $10.64
- 52 Week High
- SER $19.93
- NXN $12.45
- Technical
- Relative Strength Index (RSI)
- SER 48.48
- NXN 59.31
- Support Level
- SER $4.80
- NXN $11.69
- Resistance Level
- SER $5.64
- NXN $11.94
- Average True Range (ATR)
- SER 0.23
- NXN 0.12
- MACD
- SER 0.04
- NXN 0.01
- Stochastic Oscillator
- SER 20.16
- NXN 54.82
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.
About NXN Nuveen New York Select Tax-Free Income Portfolio
Nuveen NY Select Tax-Free Income Port is a diversified closed-end management investment company. Its investment objective are to provide current income exempt from regular federal and New Jersey income tax, and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.